Cheng C H, Costall B, Kelly M E, Naylor R J
School of Pharmacy, University of Bradford, West Yorkshire, UK.
Eur J Pharmacol. 1994 Apr 1;255(1-3):39-49. doi: 10.1016/0014-2999(94)90080-9.
The involvement of 5-HT receptors in behavioural responding to an aversive situation was investigated in the mouse light/dark test. The administration of 5-hydroxytryptophan (5-HTP) (12.5-50 mg/kg i.p.) increased brain 5-HT turnover and inhibited mouse behaviour in the light/dark test box. The 5-HT2C/5-HT2A receptor antagonists methysergide (1.0 and 5.0 mg/kg i.p.) and ritanserin (0.1-1.0 mg/kg i.p.) antagonised (methysergide) or reversed (ritanserin) the effects of 5-HTP to an increased exploration of the light compartment; a low dose of the 5-HT3 receptor antagonist ondansetron (0.01 mg/kg i.p.) had a similar effect. The disinhibitory effect of the 5-HTP/ritanserin interaction was antagonised by the 5-HT3/5-HT4 receptor antagonists SDZ205-557 (0.001-0.1 mg/kg) and a high dose of tropisetron (1.0 mg/kg i.p.) but not by ondansetron (1.0 mg/kg i.p.). At these doses tropisetron and ondansetron had no effect in their own right. Thus the dominant effect of 5-HTP in the mouse is to inhibit behaviour, a response mediated via 5-HT2C/5-HT2A and 5-HT3 receptors. A 5-HT4 receptor may effect an opposing disinhibitory potential as revealed by ritanserin.
在小鼠明暗试验中研究了5-羟色胺(5-HT)受体在对厌恶情境行为反应中的作用。腹腔注射5-羟色氨酸(5-HTP)(12.5 - 50毫克/千克)可增加脑内5-HT的更新率,并抑制小鼠在明暗试验箱中的行为。5-HT2C/5-HT2A受体拮抗剂麦角酰二乙胺(1.0和5.0毫克/千克,腹腔注射)和利坦色林(0.1 - 1.0毫克/千克,腹腔注射)可拮抗(麦角酰二乙胺)或逆转(利坦色林)5-HTP对增加光箱探索行为的作用;低剂量的5-HT3受体拮抗剂昂丹司琼(0.01毫克/千克,腹腔注射)也有类似作用。5-HTP/利坦色林相互作用的去抑制作用可被5-HT3/5-HT4受体拮抗剂SDZ205 - 557(0.001 - 0.1毫克/千克)和高剂量的托烷司琼(1.0毫克/千克,腹腔注射)拮抗,但不能被昂丹司琼(1.0毫克/千克,腹腔注射)拮抗。在这些剂量下,托烷司琼和昂丹司琼本身无作用。因此,5-HTP对小鼠的主要作用是抑制行为,这种反应是通过5-HT2C/5-HT2A和5-HT3受体介导的。如利坦色林所示,5-HT4受体可能具有相反的去抑制作用。